Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'BRUCKE T' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 58 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Cunnington, R; Lalouschek, W; Dirnberger, G; Walla, P; Lindinger, G; Asenbaum, S; Brucke, T; Lang, W
      A medial to lateral shift in pre-movement cortical activity in hemi-Parkinson's disease

      CLINICAL NEUROPHYSIOLOGY
    2. Tribl, GG; Wober, C; Schonborn, V; Brucke, T; Deecke, L; Panzer, S
      Amantadine in Parkinson's disease: lymphocyte subsets and IL-2 secreting Tcell precursor frequencies

      EXPERIMENTAL GERONTOLOGY
    3. Riederer, P; Brucke, T; Buhmann, C; Muller, T; Schwartz, A; Storch, A; Winner, B
      Workshop II: 'Neuroprotection' - the Lugano consensus (vol 247, pg 36, 2000)

      JOURNAL OF NEUROLOGY
    4. Alf, C; Bancher, C; Berger, O; Binder, H; Brucke, T; Deecke, L; Domanovits, H; Donis, J; Catterbauer, E; Glawar, B; Grisold, W; Heimberger, K; Hirschl, M; Hoberstorfer, M; Kaff, A; Kristoferitsch, W; Laggner, A; Lalouschek, W; Lang, W; Lassmann, J; Mamoli, B; Pankl, W; Parigger, S; Podreka, I; Prainer, C; Schlager, T; Schlederer, M; Schmidbauer, M; Schnaberth, G; Segall, B
      The Vienna Stroke Registry - Objectives and methodology

      WIENER KLINISCHE WOCHENSCHRIFT
    5. Willeit, M; Stastny, J; Pirker, W; Praschak-Rieder, N; Neumeister, A; Asenbaum, S; Tauscher, J; Fuchs, K; Sieghart, W; Hornik, K; Aschauer, HN; Brucke, T; Kasper, S
      No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism

      BIOLOGICAL PSYCHIATRY
    6. Tauscher, J; Pirker, W; Willeit, M; de Zwaan, M; Bailer, U; Neumeister, A; Asenbaum, S; Lennkh, C; Praschak-Rieder, N; Brucke, T; Kasper, S
      [I-123] beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa

      BIOLOGICAL PSYCHIATRY
    7. Barnas, C; Quiner, S; Tauscher, J; Hilger, E; Willeit, M; Kufferle, B; Asenbaum, S; Brucke, T; Rao, ML; Kasper, S
      In vivo I-123 IBZM SPECT imaging of striatal dopamine 2 receptor occupancyin schizophrenic patients

      PSYCHOPHARMACOLOGY
    8. Pirker, W; Asenbaum, S; Bencsits, G; Prayer, D; Gerschlager, W; Deecke, L; Brucke, T
      [I-123]beta-CIT SPECT in multiple system atrophy, progressive supranuclearpalsy, and corticobasal degeneration

      MOVEMENT DISORDERS
    9. Muller-Vahl, KR; Berding, G; Brucke, T; Kolbe, H; Meyer, GJ; Hundeshagen, H; Dengler, R; Knapp, WH; Emrich, HM
      Dopamine transporter binding in Gilles de la Tourette syndrome

      JOURNAL OF NEUROLOGY
    10. Brucke, T; Djamshidian, S; Bencsits, G; Pirker, W; Asenbaum, S; Podreka, I
      SPECT and PET imaging of the dopaminergic system in Parkinson's disease

      JOURNAL OF NEUROLOGY
    11. Riederer, P; Brucke, T; Muller, T; Schwartz, A; Storch, A; Winner, B
      Workshop II: "Neuroprotection" - the Lugano consensus

      JOURNAL OF NEUROLOGY
    12. Vesely, C; Kufferle, B; Brucke, T; Kasper, S
      Remission of severe tardive dyskinesia in a schizophrenic patient treated with the atypical antipsychotic substance quetiapine

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    13. Pirker, W; Asenbaum, S; Hauk, M; Kandlhofer, S; Tauscher, J; Willeit, M; Neumeister, A; Praschak-Rieder, N; Angelberger, P; Brucke, T
      Imaging serotonin and dopamine transporters with I-123-beta-CIT SPECT: Binding kinetics and effects of normal aging

      JOURNAL OF NUCLEAR MEDICINE
    14. Willeit, M; Praschak-Rieder, N; Neumeister, A; Pirker, W; Asenbaum, S; Vitouch, O; Tauscher, J; Hilger, E; Stastny, J; Brucke, T; Kasper, S
      [I-123]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder

      BIOLOGICAL PSYCHIATRY
    15. Neumeister, A; Pirker, W; Willeit, M; Praschak-Rieder, N; Asenbaum, S; Brucke, T; Kasper, S
      Seasonal variation of availability of serotonin transporter binding sites in healthy female subjects as measured by [I-123]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography

      BIOLOGICAL PSYCHIATRY
    16. Tauscher, J; Pirker, W; de Zwaan, M; Asenbaum, S; Brucke, T; Kasper, S
      In vivo visualization of serotonin transporters in the human brain during fluoxetine treatment

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    17. Pirker, W; Baumgartner, C; Brugger, S; Prayer, D; Kandlhofer, S; Asenbaum, S; Deecke, L; Brucke, T; Lange, KW
      Severe akinetic syndrome resulting from a bilateral basal ganglia lesion following bone marrow transplantation

      MOVEMENT DISORDERS
    18. Almer, G; Hainfellner, JA; Brucke, T; Jellinger, K; Kleinert, R; Bayer, G; Windl, O; Kretzschmar, HA; Hill, A; Sidle, K; Collinge, J; Budka, H
      Fatal familial insomnia: a new Austrian family

      BRAIN
    19. Tauscher, J; Kufferle, B; Asenbaum, S; Fischer, P; Pezawas, L; Barnas, C; Tauscher-Wisniewski, S; Brucke, T; Kasper, S
      In vivo I-123 IBZM SPECT imaging of striatal dopamine-2 receptor occupancyin schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol

      PSYCHOPHARMACOLOGY
    20. BARON JC; LENZI GL; BRUCKE T; FRACKOWIAK R; HEISS WD; PANTANO P; PAULSON OB; ROSSINI PM; SCHOENEN J; TOUBOUL PJ; VIONDURY J; VONKUMMER R
      NEUROIMAGING IN EUROPEAN ACADEMIC NEUROLOGY - PRESENT STATUS AND FUTURE ORGANIZATION

      European journal of neurology
    21. KASPER S; TAUSCHER J; KUFFERLE B; HESSELMANN B; BARNAS C; BRUCKE T
      IBZM-SPECT IMAGING OF DOPAMINE D-2 RECEPTORS WITH TYPICAL AND ATYPICAL ANTIPSYCHOTICS

      European psychiatry
    22. WILLEIT M; BARNAS C; TAUSCHER J; KUFFERLE B; KRENN P; ASENBAUM S; BRUCKE T; KASPER S
      VISUALIZATION OF DOPAMINE-2 RECEPTOR BLOCKADE IN PSYCHOTIC-PATIENTS TREATED WITH ZOTEPINE

      Schizophrenia research
    23. NAUMANN M; PIRKER W; REINERS K; LANGE KW; BECKER G; BRUCKE T
      IMAGING THE PRE-SYNAPTIC AND POSTSYNAPTIC SIDE OF STRIATAL DOPAMINERGIC SYNAPSES IN IDIOPATHIC CERVICAL DYSTONIA - A SPECT STUDY USING [I-123] EPIDEPRIDE AND [I-123] BETA-CIT

      Movement disorders
    24. Asenbaum, S; Pirker, W; Angelberger, P; Bencsits, G; Pruckmayer, M; Brucke, T
      [I-123]beta-CIT and SPECT in essential tremor and Parkinson's disease

      JOURNAL OF NEURAL TRANSMISSION
    25. ASENBAUM S; BRUCKE T; PIRKER W; PIETRZYK U; PODREKA I
      IMAGING OF CEREBRAL BLOOD-FLOW WITH TECHNETIUM-99M-HMPAO AND TECHNETIUM-99M-ECD - A COMPARISON

      The Journal of nuclear medicine
    26. STANDHARDT H; PIRKER W; BRUCKE T; ALESCH F; KOOS WT
      BILATERAL CHRONIC ELECTRICAL-STIMULATION OF THE GLOBUS-PALLIDUS INTERNUS FOR THE TREATMENT OF ADVANCED PARKINSONS-DISEASE - A 2-YEAR FOLLOW-UP

      Neurology
    27. WENGER S; MEISINGER V; BRUCKE T; DEECKE L
      ACUTE PORPHYRIC NEUROPATHY DURING PREGNANCY - EFFECT OF HEMATIN THERAPY

      European neurology
    28. TAUSCHER J; PIRKER W; LENNKH C; DEZWAAN M; STRNAD A; BRUCKE T; KASPER S
      IN-VIVO VISUALIZATION OF SEROTONIN TRANSPORTERS DURING TREATMENT WITHSSRI

      Biological psychiatry
    29. TAUSCHER J; PIRKER W; LENNKH C; DEZWAAN M; STRNAD A; NEUMEISTER A; WILLEIT M; PRASCHAKRIEDER N; BRUCKE T; KASPER S
      ELEVATED BETA-CIT BINDING IN PATIENTS WITH BULIMIA-NERVOSA

      Biological psychiatry
    30. KASPER S; TAUSCHER J; KUFFERLE B; BARNAS C; HESSELMANN B; ASENBAUM S; PODREKA I; BRUCKE T
      SERTINDOLE AND DOPAMINE D-2 RECEPTOR OCCUPANCY IN COMPARISON TO RISPERIDONE, CLOZAPINE AND HALOPERIDOL - A I-123 IBZM SPECT STUDY

      Psychopharmacology
    31. LEHRNER JP; BRUCKE T; DALBIANCO P; GATTERER G; KRYSPINEXNER I
      OLFACTORY FUNCTIONS IN PARKINSONS-DISEASE AND ALZHEIMERS-DISEASE

      Chemical senses
    32. BRUCKE T; ASENBAUM S; PIRKER W; DJAMSHIDIAN S; WENGER S; WOBER C; MULLER C; PODREKA I
      MEASUREMENT OF THE DOPAMINERGIC DEGENERATION IN PARKINSONS-DISEASE WITH [I-123] BETA-CIT AND SPECT - CORRELATION WITH CLINICAL FINDINGS ANDCOMPARISON WITH MULTIPLE SYSTEM ATROPHY AND PROGRESSIVE SUPRANUCLEAR PALSY

      Journal of neural transmission. Supplementum
    33. PIRKER W; ASENBAUM S; WENGER S; KORNHUBER J; ANGELBERGER P; DEECKE L; PODREKA I; BRUCKE T
      IODINE-123-EPIDEPRIDE-SPECT - STUDIES IN PARKINSONS-DISEASE, MULTIPLESYSTEM ATROPHY AND HUNTINGTONS-DISEASE

      The Journal of nuclear medicine
    34. ASENBAUM S; BRUCKE T; PIRKER W; PODREKA I; ANGELBERGER P; WENGER S; WOBER C; MULLER C; DEECKE L
      IMAGING OF DOPAMINE TRANSPORTERS WITH IODINE-123-BETA-CIT AND SPECT IN PARKINSONS-DISEASE

      The Journal of nuclear medicine
    35. TAUSCHER J; KUFFERLE B; BARNAS C; ASENBAUM S; BRUCKE T; KASPER S
      D-2 RECEPTOR OCCUPANCY WITH QUETIAPINE, CLOZAPINE, RISPERIDONE AND HALOPERIDOL

      Biological psychiatry
    36. TAUSCHER J; KUFFERLE B; BARNAS C; ASENBAUM S; BRUCKE T; KASPER S
      PREMEDICATION INFLUENCED D-2 RECEPTOR OCCUPANCY WITH QUETIAPINE AND SERTINDOLE

      Biological psychiatry
    37. WILLEIT M; PRASCHAKRIEDER N; ASENBAUM S; NEUMEISTER A; HESSELMANN B; HABELER A; IBATOULLINA E; TAUSCHER J; PIRKER W; BRUCKE T; KASPER S
      SEROTONIN TRANSPORTER DENSITY IN DEPRESSED SAD PATIENTS

      Biological psychiatry
    38. KASPER S; KUFFERLE B; TAUSCHER J; ASENBAUM S; BARNAS C; HESSELMANN B; PODREKA I; BRUCKE T
      DOPAMINE D-2 RECEPTOR-BINDING IN TYPICAL AND ATYPICAL NEUROLEPTICS

      Biological psychiatry
    39. KUFFERLE B; TAUSCHER J; ASENBAUM S; VESELY C; PODREKA I; BRUCKE T; KASPER S
      IBZM SPECT IMAGING OF STRIATAL DOPAMINE-2 RECEPTORS IN PSYCHOTIC-PATIENTS TREATED WITH THE NOVEL ANTIPSYCHOTIC SUBSTANCE QUETIAPINE IN COMPARISON TO CLOZAPINE AND HALOPERIDOL

      Psychopharmacology
    40. TAUSCHER J; KUFFERLE B; ASENBAUM S; BRUCKE T; KASPER S
      PREVIOUS TREATMENT AS A CONFOUNDING VARIABLE IN STUDIES WITH NOVEL ANTIPSYCHOTICS - 2 CASES OF HIGH DOPAMINE-2 RECEPTOR OCCUPANCY WITH QUETIAPINE

      Psychopharmacology
    41. KUFFERLE B; BRUCKE T; TOPITZSCHRATZBERGER A; TAUSCHER J; GOSSLER R; VESELY C; ASENBAUM S; PODREKA I; KASPER S
      STRIATAL DOPAMINE-2 RECEPTOR OCCUPANCY IN PSYCHOTIC-PATIENTS TREATED WITH RISPERIDONE

      PSYCHIATRY RESEARCH-NEUROIMAGING
    42. ODER W; BRUCKE T; KOLLEGGER H; SPATT J; ASENBAUM S; DEECKE L
      DOPAMINE D2 RECEPTOR-BINDING IS REDUCED IN WILSONS-DISEASE - CORRELATION OF NEUROLOGICAL DEFICITS WITH STRIATAL I-123 IODOBENZAMIDE BINDING

      Journal of neural transmission
    43. PIRKER W; RIEDL M; LUGER A; CZECH T; ROSSLER K; ASENBAUM S; ANGELBERGER P; KORNHUBER J; DEECKE L; PODREKA I; BRUCKE T
      DOPAMINE D2 RECEPTOR IMAGING IN PITUITARY-ADENOMAS USING IODINE-123-EPIDEPRIDE AND SPECT

      The Journal of nuclear medicine
    44. TAUSCHER J; KUFFERLE B; NEUMEISTER A; ASENBAUM S; BRUCKE T; PODREKA I; KASPER S
      IBZM-SPECT SHOWS LOW STRIATAL D2 BLOCKADE UNDER THERAPY WITH SEROQUEL

      Biological psychiatry
    45. KASPER S; TAUSCHER J; KUFFERLE B; HEIDEN A; NEUMEISTER A; BARNAS C; ASENBAUM S; PODREKA I; BRUCKE T
      D2 - RECEPTOR IMAGING (SPECT) AS A TOOL FOR MEASURING THE EFFICACY AND SIDE-EFFECT PROFILE OF TREATMENT WITH NEUROLEPTICS

      Biological psychiatry
    46. KORNHUBER J; BRUCKE T; ANGELBERGER P; ASENBAUM S; PODREKA I
      SPECT IMAGING OF DOPAMINE-RECEPTORS WITH [I-123] EPIDEPRIDE - CHARACTERIZATION OF UPTAKE IN THE HUMAN BRAIN

      Journal of neural transmission
    47. PIRKER W; ASENBAUM S; KASPER S; WALTER H; ANGELBERGER P; KOCH G; POZZERA A; DEECKE L; PODREKA I; BRUCKE T
      BETA-CIT SPECT DEMONSTRATES BLOCKADE OF 5HT-UPTAKE SITES BY CITALOPRAM IN THE HUMAN BRAIN IN-VIVO

      Journal of neural transmission
    48. BRUCKE T; WOBER C; PODREKA I; WOBERBINGOL C; ASENBAUM S; AULL S; WENGER S; ILIEVA D; HARASKOVANDERMEER C; WESSELY P; DEECKE L
      D-2 RECEPTOR BLOCKADE BY FLUNARIZINE AND CINNARIZINE EXPLAINS EXTRAPYRAMIDAL SIDE-EFFECTS - A SPECT STUDY

      Journal of cerebral blood flow and metabolism
    49. ASENBAUM S; ZEITLHOFER J; SALETU B; FREY R; BRUCKE T; PODREKA I; DEECKE L
      TECHNETIUM-99M-HMPAO SPECT IMAGING OF CEREBRAL BLOOD-FLOW DURING REM-SLEEP IN NARCOLEPTICS

      The Journal of nuclear medicine
    50. LEHRNER J; BRUCKE T; KRYSPINEXNER I; ASENBAUM S; PODREKA I
      IMPAIRED OLFACTORY FUNCTION IN PARKINSONS-DISEASE

      Lancet
    51. ASENBAUM S; REINPRECHT A; BRUCKE T; WENGER S; PODREKA I; DEECKE L
      A STUDY OF ACETAZOLAMIDE-INDUCED CHANGES IN CEREBRAL BLOOD-FLOW USINGTC-99M HMPAO SPECT IN PATIENTS WITH CEREBROVASCULAR-DISEASE

      Neuroradiology
    52. WOBER C; BRUCKE T; WOBERBINGOL C; ASENBAUM S; WESSELY P; PODREKA I
      DOPAMINE-D2 RECEPTOR BLOCKADE AND ANTIMIGRAINE ACTION OF FLUNARIZINE

      Cephalalgia
    53. PIRKER W; BRUCKE T; RIEDL M; CLODI M; LUGER A; ASENBAUM S; PODREKA I; DEECKE L
      IODINE-123-IBZM-SPECT - STUDIES IN 15 PATIENTS WITH PITUITARY-TUMORS

      Journal of neural transmission
    54. BRUCKE T; ASENBAUM S; ANGELBERGER P; KOMHUBER J; POZZERA A; HORNYKIEWICZ S; HARASKOVANDERMEER C; WENGER S; PIRKER W; PODREKA I
      QUANTIFICATION OF THE DOPAMINERGIC NERVE-CELL LOSS IN PARKINSONS-DISEASE WITH [I-123] LABELED BETA-CIT AND SPECT

      The Journal of nuclear medicine
    55. PODREKA I; BAUMGARTNER C; AULL S; KOCH G; PIETRCZYK U; LINDINGER G; OLBRICH A; HITTMAIER K; LUGER S; BRUCKE T; WIMBERGER D
      PREOPERATIVE SEIZURE MONITORING WITH HMPAO - SPECT PROLONGED EEG AND MRI

      The Journal of nuclear medicine
    56. MESZAROS K; WILLINGER U; HEIDEN AM; FUCHS K; BAUMHACKL U; BRUCKE T; FEUCHT M; FATHI N; LENZINGER E; MILLER E; RESINGER E; WOBERBINGOL C; STOMPE T; SIEGHART W; ASCHAUER HN
      HUNTINGTONS-DISEASE - (CAG) (N) REPEATS O N GENE IT-15 IN AUSTRIA

      Wiener Klinische Wochenschrift
    57. HARASKOVANDERMEER C; BRUCKE T; WENGER S; FISCHER P; DEECKE L; PODREKA I
      2 CASES OF LONG-TERM DOPAMINE D2 RECEPTOR BLOCKADE AFTER DEPOT NEUROLEPTICS

      Journal of neural transmission
    58. BRUCKE T; KORNHUBER J; ANGELBERGER P; ASENBAUM S; FRASSINE H; PODREKA I
      SPECT IMAGING OF DOPAMINE AND SEROTONIN TRANSPORTERS WITH [I-123] BETA-CIT - BINDING-KINETICS IN THE HUMAN BRAIN

      Journal of neural transmission


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/08/19 alle ore 22:51:13